GLUE
Monte Rosa Therapeutics Inc
11.70$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -228.8% | – | – | – | -135.3% | – | – | -142.8% | – | – | – | |
| – | +0.7% | +2.8% | +8.6% | +2.1% | -2.0% | -0.6% | +3.8% | -1.4% | -0.3% | -2.8% | +94.3% | – | |
| – | -8.8% | +19.6% | -7.6% | -4.9% | +4.4% | +18.6% | -7.6% | -10.8% | -1.3% | +38.1% | +100.4% | – | |
| – | +1,219.5% | -122.4% | – | – | – | -190.0% | – | – | -102.8% | – | -5,479.4% | – | |
| – | +1.8% | -18.1% | +46.1% | -80.3% | -54.1% | +767.2% | +6.8% | -61.6% | +17.8% | +143.5% | +252.8% | – | |
| – | -59.9% | -31.1% | -720.7% | – | -181.8% | +224.4% | – | +50.6% | -270.6% | +301.1% | +11.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,186.4% | -99.0% | +39,746.7% | -100.0% | +3,953.3% | -97.7% | +2,507.1% | -4.7% | +8,412.6% | +1,008.3% | +1.0% | – | |
| – | +474.0% | -141.1% | – | +84.4% | +488.2% | -247.7% | – | – | -156.5% | – | -232.8% | – | |
| – | – | -241.5% | – | – | – | -136.6% | – | – | -143.9% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.